Corporate venture capital firms invest in startups, facing uncertainty about their success. This study looked at how the reputation of the investing firm and previous investments affect the financial returns of acquiring companies. By analyzing biotechnology acquisitions, the researchers found that when a CVC firm is well-known and has previously invested in a startup, the acquiring company earns positive financial returns. This shows that these endorsements play a role in the success of acquisitions in the biotechnology industry.